1. Home
  2. AVBP vs CCNE Comparison

AVBP vs CCNE Comparison

Compare AVBP & CCNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVBP
  • CCNE
  • Stock Information
  • Founded
  • AVBP 2021
  • CCNE 1865
  • Country
  • AVBP United States
  • CCNE United States
  • Employees
  • AVBP N/A
  • CCNE N/A
  • Industry
  • AVBP
  • CCNE Major Banks
  • Sector
  • AVBP
  • CCNE Finance
  • Exchange
  • AVBP NYSE
  • CCNE Nasdaq
  • Market Cap
  • AVBP 617.4M
  • CCNE 523.6M
  • IPO Year
  • AVBP 2024
  • CCNE N/A
  • Fundamental
  • Price
  • AVBP $20.15
  • CCNE $22.47
  • Analyst Decision
  • AVBP Strong Buy
  • CCNE Hold
  • Analyst Count
  • AVBP 6
  • CCNE 1
  • Target Price
  • AVBP $39.00
  • CCNE $25.00
  • AVG Volume (30 Days)
  • AVBP 162.5K
  • CCNE 71.0K
  • Earning Date
  • AVBP 05-20-2025
  • CCNE 04-14-2025
  • Dividend Yield
  • AVBP N/A
  • CCNE 3.20%
  • EPS Growth
  • AVBP N/A
  • CCNE N/A
  • EPS
  • AVBP N/A
  • CCNE 2.34
  • Revenue
  • AVBP N/A
  • CCNE $219,886,000.00
  • Revenue This Year
  • AVBP $63.13
  • CCNE $17.91
  • Revenue Next Year
  • AVBP N/A
  • CCNE $27.71
  • P/E Ratio
  • AVBP N/A
  • CCNE $9.60
  • Revenue Growth
  • AVBP N/A
  • CCNE 1.97
  • 52 Week Low
  • AVBP $15.47
  • CCNE $18.60
  • 52 Week High
  • AVBP $36.37
  • CCNE $29.29
  • Technical
  • Relative Strength Index (RSI)
  • AVBP 51.13
  • CCNE 55.15
  • Support Level
  • AVBP $18.84
  • CCNE $22.22
  • Resistance Level
  • AVBP $21.79
  • CCNE $22.88
  • Average True Range (ATR)
  • AVBP 1.12
  • CCNE 0.62
  • MACD
  • AVBP 0.00
  • CCNE 0.14
  • Stochastic Oscillator
  • AVBP 44.50
  • CCNE 61.39

About AVBP ARRIVENT BIOPHARMA INC

ArriVent BioPharma Inc is a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers. It seeks to utilize the team's deep drug development experience to maximize the potential of the lead development candidate, furmonertinib, and advance a pipeline of novel therapeutics, such as next-generation antibody-drug conjugates, through approval and commercialization in patients suffering from cancer, with an initial focus on solid tumors.

About CCNE CNB Financial Corporation

CNB Financial Corp is providing integrated financial solutions, which create value for both consumers and businesses. These solutions encompass deposit accounts, private banking, real estate, commercial, industrial, residential and consumer loans and lines of credit, credit cards, treasury services, online banking, mobile banking, merchant credit card processing, remote deposit and accounts receivable handling. In addition, the corporation provides wealth and asset management services, retirement plans and other employee benefit plans.

Share on Social Networks: